Clinical evaluation of skeletal muscle in patients with inflammatory m
yopathies (IM) has long been hampered by difficulty in assessing the m
orphology and functional integrity of skeletal muscles. Advances in ra
diologic techniques, particularly MR imaging, have improved the abilit
y to manage patients with neuromuscular disease in general and IM in p
articular. MR imaging can probe beyond the skin to identify focal musc
le structural lesions, determine their extent, characterize their comp
osition, direct invasive procedures, and monitor therapies. This artic
le reviews the clinical, pathologic, and imaging aspects of these dise
ases.